Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SXT1596 is a novel SS18-SSX/TLE1 interaction inhibitor. SXT1596 reduces cell viability and reactivates EGR1 expression in synovial sarcoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | SXT1596 is a novel SS18-SSX/TLE1 interaction inhibitor. SXT1596 reduces cell viability and reactivates EGR1 expression in synovial sarcoma. |
Synonyms | NSC-65667, SXT-1596, NSC 65667, SXT 1596, NSC65667 |
Molecular Weight | 207.18 |
Formula | C10H9NO4 |
CAS No. | 5438-41-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SXT1596 5438-41-5 NSC-65667 SXT-1596 NSC 65667 SXT 1596 NSC65667 inhibitor inhibit